These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 16120435
21. Thermodynamics, adsorption kinetics and rheology of mixed protein-surfactant interfacial layers. Kotsmar C, Pradines V, Alahverdjieva VS, Aksenenko EV, Fainerman VB, Kovalchuk VI, Krägel J, Leser ME, Noskov BA, Miller R. Adv Colloid Interface Sci; 2009 Aug 30; 150(1):41-54. PubMed ID: 19493522 [Abstract] [Full Text] [Related]
22. Effect of SP-C on surface potential distribution in pulmonary surfactant: Atomic force microscopy and Kelvin probe force microscopy study. Hane F, Moores B, Amrein M, Leonenko Z. Ultramicroscopy; 2009 Jul 30; 109(8):968-73. PubMed ID: 19398273 [Abstract] [Full Text] [Related]
23. Modifying calf lung surfactant by hexadecanol. Alonso C, Bringezu F, Brezesinski G, Waring AJ, Zasadzinski JA. Langmuir; 2005 Feb 01; 21(3):1028-35. PubMed ID: 15667185 [Abstract] [Full Text] [Related]
24. Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics. Gómez-Gil L, Schürch D, Goormaghtigh E, Pérez-Gil J. Biophys J; 2009 Nov 18; 97(10):2736-45. PubMed ID: 19917227 [Abstract] [Full Text] [Related]
25. Effects of eicosane, a component of nanoparticles in diesel exhaust, on surface activity of pulmonary surfactant monolayers. Kanno S, Furuyama A, Hirano S. Arch Toxicol; 2008 Nov 18; 82(11):841-50. PubMed ID: 18488198 [Abstract] [Full Text] [Related]
26. Interfacial organizations of gel phospholipid and cholesterol in bovine lung surfactant films. Nag K, Fritzen-Garcia M, Devraj R, Panda AK. Langmuir; 2007 Apr 10; 23(8):4421-31. PubMed ID: 17341098 [Abstract] [Full Text] [Related]
27. Multilayers at the surface of solutions of exogenous lung surfactant: direct observation by neutron reflection. Follows D, Tiberg F, Thomas RK, Larsson M. Biochim Biophys Acta; 2007 Feb 10; 1768(2):228-35. PubMed ID: 17156743 [Abstract] [Full Text] [Related]
28. Effects of oligomerization and secondary structure on the surface behavior of pulmonary surfactant proteins SP-B and SP-C. Wüstneck N, Wüstneck R, Perez-Gil J, Pison U. Biophys J; 2003 Mar 10; 84(3):1940-9. PubMed ID: 12609896 [Abstract] [Full Text] [Related]
29. Role of surfactant protein A (SP-A)/lipid interactions for SP-A functions in the lung. Casals C. Pediatr Pathol Mol Med; 2001 Mar 10; 20(4):249-68. PubMed ID: 11486733 [Abstract] [Full Text] [Related]
30. Structural characterization of the monolayer-multilayer transition in a pulmonary surfactant model: IR studies of films transferred at continuously varying surface pressures. Mao G, Desai J, Flach CR, Mendelsohn R. Langmuir; 2008 Mar 04; 24(5):2025-34. PubMed ID: 18198907 [Abstract] [Full Text] [Related]
31. Palmitoylation as a key factor to modulate SP-C-lipid interactions in lung surfactant membrane multilayers. Roldan N, Goormaghtigh E, Pérez-Gil J, Garcia-Alvarez B. Biochim Biophys Acta; 2015 Jan 04; 1848(1 Pt A):184-91. PubMed ID: 25306965 [Abstract] [Full Text] [Related]
32. Effects of including an N-terminal insertion region and arginine-mimetic side chains in helical peptoid analogues of lung surfactant protein B. Seurynck-Servoss SL, Dohm MT, Barron AE. Biochemistry; 2006 Oct 03; 45(39):11809-18. PubMed ID: 17002281 [Abstract] [Full Text] [Related]
33. Inactivation of pulmonary surfactant by silicone oil in vitro and in ventilated immature rabbits. Stichtenoth G, Linderholm B, Almlén A, Björkman MH, Byman I, Nordling K, Robertson B, Johansson J, Herting E, Curstedt T. Crit Care Med; 2009 May 03; 37(5):1750-6. PubMed ID: 19325472 [Abstract] [Full Text] [Related]
34. Palmitoylation of lung surfactant protein SP-C alters surface thermodynamics, but not protein secondary structure or orientation in 1,2-dipalmitoylphosphatidylcholine langmuir films. Flach CR, Gericke A, Keough KM, Mendelsohn R. Biochim Biophys Acta; 1999 Jan 12; 1416(1-2):11-20. PubMed ID: 9889301 [Abstract] [Full Text] [Related]
35. Fluorocarbon-hybrid pulmonary surfactants for replacement therapy--a Langmuir monolayer study. Nakahara H, Lee S, Krafft MP, Shibata O. Langmuir; 2010 Dec 07; 26(23):18256-65. PubMed ID: 21049919 [Abstract] [Full Text] [Related]
36. Two hydrophobic protein fractions of ovine pulmonary surfactant: isolation, characterization, and biophysical activity. Bünger H, Krüger RP, Pietschmann S, Wüstneck N, Kaufner L, Tschiersch R, Pison U. Protein Expr Purif; 2001 Nov 07; 23(2):319-27. PubMed ID: 11676608 [Abstract] [Full Text] [Related]
37. Hydrophobic surfactant proteins and their analogues. Walther FJ, Waring AJ, Sherman MA, Zasadzinski JA, Gordon LM. Neonatology; 2007 Nov 07; 91(4):303-10. PubMed ID: 17575474 [Abstract] [Full Text] [Related]
38. Rheological behavior and parameters of the in vitro model of lung surfactant systems: the role of the main phospholipid component. Antonova N, Todorov R, Exerowa D. Biorheology; 2003 Nov 07; 40(5):531-43. PubMed ID: 12897419 [Abstract] [Full Text] [Related]
39. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition. Echaide M, Autilio C, López-Rodríguez E, Cruz A, Pérez-Gil J. Sci Rep; 2020 Jan 28; 10(1):1385. PubMed ID: 31992800 [Abstract] [Full Text] [Related]
40. Inflammatory reaction and alterations of pulmonary surfactant in Pseudomonas Aeruginosa pneumonia in immunocompromised rats. Qu J, Li Z, He L, Sun B, Chen X. Chin Med J (Engl); 2002 Jul 28; 115(7):1099-100. PubMed ID: 12173603 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]